Manulife (Manufacturers Life Insurance)’s Sana Biotechnology SANA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $793K | Buy |
290,411
+316
| +0.1% | +$863 | ﹤0.01% | 1933 |
|
|
2025
Q1 | $487K | Sell |
290,095
-18,127
| -6% | -$30.5K | ﹤0.01% | 2158 |
|
|
2024
Q4 | $502K | Sell |
308,222
-1,893
| -0.6% | -$3.09K | ﹤0.01% | 2238 |
|
|
2024
Q3 | $1.29M | Sell |
310,115
-1,916
| -0.6% | -$7.97K | ﹤0.01% | 1780 |
|
|
2024
Q2 | $1.7M | Buy |
312,031
+23,157
| +8% | +$126K | ﹤0.01% | 1556 |
|
|
2024
Q1 | $2.89M | Buy |
288,874
+25,397
| +10% | +$254K | ﹤0.01% | 1387 |
|
|
2023
Q4 | $1.07M | Buy |
263,477
+48,246
| +22% | +$197K | ﹤0.01% | 1760 |
|
|
2023
Q3 | $833K | Buy |
215,231
+11,399
| +6% | +$44.1K | ﹤0.01% | 1832 |
|
|
2023
Q2 | $1.21M | Buy |
203,832
+1,927
| +1% | +$11.5K | ﹤0.01% | 1565 |
|
|
2023
Q1 | $660K | Sell |
201,905
-1,411
| -0.7% | -$4.61K | ﹤0.01% | 1837 |
|
|
2022
Q4 | $777K | Buy |
203,316
+59,742
| +42% | +$228K | ﹤0.01% | 1735 |
|
|
2022
Q3 | $817K | Sell |
143,574
-639
| -0.4% | -$3.64K | ﹤0.01% | 1695 |
|
|
2022
Q2 | $908K | Buy |
144,213
+24,917
| +21% | +$157K | ﹤0.01% | 1693 |
|
|
2022
Q1 | $976K | Buy |
119,296
+73,561
| +161% | +$602K | ﹤0.01% | 1766 |
|
|
2021
Q4 | $713 | Buy |
45,735
+320
| +0.7% | +$5 | ﹤0.01% | 2036 |
|
|
2021
Q3 | $1.02M | Buy |
45,415
+27,979
| +160% | +$630K | ﹤0.01% | 1820 |
|
|
2021
Q2 | $343K | Buy |
+17,436
| New | +$343K | ﹤0.01% | 2713 |
|